United arab emirates - Events
The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. With rapid advances in structural biology, computation, and screening, the race is on to validate new GPCRs, understand dynamic activation mechanisms, and develop assays that better predict therapeutic efficacy and guide smarter candidate selection.
Returning as the only industry-led meeting dedicated to GPCR drug discovery, the 5th GPCR-Targeted Drug Discovery Summit features a jam-packed agenda featuring new expert voices, and fresh insights spanning the latest targets, tools, and therapeutic strategies.
Join 80+ GPCR-focused leaders across biopharma to share insights, build collaborations, and accelerate ne…
Regulatory and governmental momentum is forcing change, fast:
The Senate have recently cleared the FDA Modernization Act 3.0The FDA have developed a roadmap that’s abandoning animal testing for mAbsNIH have closed the door on animal-only grantsThe UK join the plan to phase out animal testing, announced by the Science Minster Lord Vallance
Meanwhile, your pipelines are chasing novel targets that in vivo models can't predict.
The 11th 3D Tissue Models Summit is where the industry comes to solve this. As the only industry-led forum dedicated to advancing organoids, organ-on-chip, and MPS, you'll connect with scientists from AbbVie, Novartis, Vertex, and many more who are validating these models, securing regulatory buy-in, and making them work at scale. The shift is happening, so make sure yo…
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.
The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not guaranteed at approval. Addressing manufacturing costs, durability and long-term commercial viability is now mission critical for developers of TCR-based cell and biologic therapies.
Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the 7th TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Connect with and hear directly from senior leaders driving progress at the forefront of the field, including…
The 4th Nasal Formulation and Delivery Summit is uniting formulation, delivery, and product development leaders from across pharma and biotech to advance the development of safe, effective, and commercially viable intranasal therapies. As intranasal delivery gains validation across systemic, CNS, and emergency-use indications, the pressure to optimize formulations, align drug–device strategies, and generate predictive preclinical and clinical data has never been greater.
In an era of accelerating approvals, expanding modalities, and heightened regulatory scrutiny, teams must move beyond proof-of-concept to ensure intranasal programs are scalable, translatable, and fit for commercialization. Success now depends on solving formulation and delivery challenges early, while designing deve…
The UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies and others. Serving as a global gateway, it also connects the UK ecosystem with international partners to drive strategic collaborations through dealmaking, innovation, networking and finding new clients and partners.
Achieving precise extrahepatic delivery remains one of the biggest challenges in the LNP field. However, with AbbVie’s acquisition of Capstan Therapeutics and BMS’s acquisition of Orbital Therapeutics, the industry’s confidence in targeted LNPs has never been higher!
Returning to Boston in June 2026, the 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit is bringing together industry pioneers and leading delivery experts to showcase the latest advances in novel targeting ligands and innovative lipid-based technologies. Across 3 jam-packed days, attendees will gain in-depth technical insights into accelerating the delivery of mRNA, RNA, gene-editing, and cell therapy payloads to extrahepatic tissues, including immune cells, adipose tissues, muscle, and more.
With world-class speaker…
Establish Procurement Excellence for R and D Innovation, Drive Supplier Value and Accelerate Study Timelines Through AI and Strategic Initiatives.
R and D procurement is undergoing a major transformation as organizations shift from transactional buying to strategic, innovation-driven value creation across the development pipeline. Procurement teams are navigating unprecedented complexity: strengthening global sourcing models amid geopolitical instability, extracting true value from CRO and CMO partnerships, integrating AI and orchestration tools to streamline operations, and aligning internal stakeholders around business continuity, speed, and scientific ambition. At the same time, the demands of emerging modalities, digital trial technologies, and evolving supplier ecosystems require more…
Foster Innovation and Collaboration at the 10th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference!
Join us in June 2026 as SAE Media Group's renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.
This year's conference will bring a brand NEW focus day followed by the two-day main conference offering an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.
What You'll Gain:
Actionable insights to strengthen your drug-device portfolio.Opportunities to network with key players shaping the injectable drug delivery landscape.A future-focused perspective…
The Global Infectious Diseases and One Health Conference (GIOH 2026) in London, United Kingdom, Online from August 17–19, 2026, unites health professionals, scientists, and policymakers committed to strengthening preparedness against infectious threats. The One Health congress offers a global perspective on how collaborative efforts can prevent and mitigate disease outbreaks.
Core discussions will focus on pandemic intelligence, surveillance systems, climate-driven infections, biosecurity frameworks, and antibiotic stewardship. Renowned experts will share strategies that enhance early detection, containment, and cross-sector coordination.
Participants will gain access to interactive workshops, expert dialogues, and live demonstrations showcasing new technologies that transform infectious d…
